Fig. 1 · Structure
Documents & Downloads
Darotropium bromide
Muscarinic Antagonist
Darotropium bromide is a long-acting muscarinic antagonist that targets muscarinic acetylcholine receptors. Its primary biological activity is the blockade of these receptors, resulting in bronchodilation and reduced airway resistance. This compound is primarily used in research related to chronic obstructive pulmonary disease (COPD), aiding in the investigation of its therapeutic potential and effects on pulmonary function.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| Actions | Antagonist |
| CAS Number | 850607-58-8 |
| Applications | Muscarinic Antagonist |
| Formula | C24H29BrN2 |
| Molecular Weight | 425.40 |
| Synonyms | GSK233705 |
| SMILES | [H][C@]1(CC(C2=CC=CC=C2)(C#N)C3=CC=CC=C3)C[C@]4([H])[N+](C)(C)[C@@]([H])(CC4)C1.[Br-] |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.